Bank of Montreal
CLCD

Bank of Montreal’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Bank of Montreal’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,000
Closed -$106K – 4343
2016
Q4 		$106K Buy
+3,000
New +$106K ﹤0.01% 2810

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Bank of Montreal's CLCD Position: Q1 2017 in Review

Bank of Montreal sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 3,000 shares — an estimated $106K sold.

Bank of Montreal first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $106K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Bank of Montreal reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Bank of Montreal sold 3,000 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $106K.
  • Bank of Montreal first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Bank of Montreal's CoLucid Pharmaceuticals, Inc. position peaked at $106K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Bank of Montreal's 13F filing for Q1 2017, filed 11 Apr 2017.